PHILADELPHIA, July 17, 2019 /PRNewswire/ -- Advocates, supporters, community leaders and healthcare providers join PCOS Challenge: The Na

ABBOTT PARK, Ill., July 17, 2019 /PRNewswire/ -- Abbott (NYSE: ABT) today announced financial results for the second quarter ended June 30, 2019.Second-quarter worldwide sales of $8.0 billion increased 2.7 percent on a reported basis and 7.5 percent on an organic* basis. Reported diluted EPS from continuing

DUBLIN, July 17, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company with more than 70 years of heritage in eye care, today announced that the U.S. Food and Drug Administration (FDA) has accepted the company's New Drug Application (NDA) for Bimatoprost Sustained-Release (SR). Bimatoprost SR if approved would be the first-in-class sustai

AUSTIN, Texas, July 17, 2019 /PRNewswire/ -- Elios Therapeutics, a biopharmaceutical company developing innovative autologous, particle-delivered, dendritic cell cancer vaccines, today announced positive top-line results from the Company's prospective, randomized, double-blind, placebo-controlled Phase IIb clinical trial evaluating its lead immuno-oncology candidate, the

VANCOUVER, British Columbia, July 17, 2019 /PRNewswire/ -- MYM Nutraceuticals Inc., (CSE: MYM) (CSE: MYM.CN) (OTCBB: MYMMF) ("MYM" or "The Company") announces it has closed the second tranche of its non-brokered private placement announced on July 5, 2019 of 2,528,174 units at a price of $0.324 for gro

VANCOUVER, July 17, 2019 /PRNewswire/ - Choom™ (CSE: CHOO; OTCQB: CHOOF), is pleased to announce that, pursuant a convertible debenture issued to Choom by Coastal Green Holdings Ltd., Choom will, on conversion of the debenture, acquire a 19.9% equity interest in Coastal Green.

HOUSTON, July 17, 2019 /PRNewswire/ --

PALO ALTO, Calif., July 17, 2019 /PRNewswire/ -- HGGC, a leading middle-market private equity firm, today announced it has agreed to the sale of a minority stake in Nutraceutical International Corporation—a vertically integrated manufacturer, marketer, and distributor of branded nutritional supplements, personal care, and other natural products—to Snapdragon

CAMBRIDGE, Mass., July 17, 2019 /PRNewswire/ -- EIP Pharma, Inc., a CNS-focused therapeutics company, today announced that new preclinical data regarding neflamapimod were presented at the AAIC 2019 scientific meeting in Los Angeles, CA (July 14-18, 2019). 

BILLERICA, Mass., July 17, 2019 /PRNewswire/ -- Bruker Corporation (Nasdaq: BRKR) has been advised that former board member, Mr. Joerg C. Laukien, has authorized a block sale of Bruker shares as part of his retirement planning and portfolio diversification.  Joerg Laukien retired from the Bruker board of